Murakami M, Sakai H, Kodama A, Yanai T, Mori T, Maruo K, Masegi T
Laboratory of Veterinary Pathology, Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, Yanagido, Gifu, Japan.
Histol Histopathol. 2009 Apr;24(4):437-46. doi: 10.14670/HH-24.437.
We performed immunohistochemical investigation of the basement membrane (BM) components, namely, type IV collagen and laminin, in 83 canine hemangiosarcomas (HSAs), 22 hemangiomas, and some granulation tissues (GTs). Additionally, we analyzed the expression and activities of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP (MT1-MMP) using the same samples by immunohistochemistry and gelatin zymography to investigate whether MMPs were associated with the BM degradation. In immunohistochemistry for the BM components, many HSAs showed discontinuous linear/negative immunoreactivity in the BM (type IV collagen: 49.4%/14.5%, laminin: 60.3%/10.8%, respectively). In contrast, almost all hemangiomas showed continuous staining in the BM (type IV collagen: 90.9%, laminin: 95.5%, respectively). Interestingly, positive cytoplasmic immunoreactivity for type IV collagen and laminin was observed in 97.6% and 91.6% HSA, respectively. Although MMP-9 immunoreactivity wasn't detected in neoplastic and active angiogenic endothelial cells (ECs), MMP-2 was detected in all ECs of GTs and in neoplastic cells of both vascular tumors. A strong immunoreactivity for MT1-MMP was observed in active angiogenic ECs in GTs and in neoplastic ECs in HSAs. However, almost all hemangiomas showed weak/negative immunoreactivity. In gelatin zymography, significantly strong activity of active MMP-2 was observed in HSAs, similar to that in active angiogenesis in GTs; however, weak/no activity of active MMP-2 was detected in hemangiomas. In canine HSA, neoplastic cells had active MMP-2, possibly activated by MT1-MMP, and discontinuous status of BM might be associated with activity of active MMP-2.
我们对83例犬血管肉瘤(HSA)、22例血管瘤以及一些肉芽组织(GT)进行了基底膜(BM)成分(即IV型胶原和层粘连蛋白)的免疫组织化学研究。此外,我们使用相同样本通过免疫组织化学和明胶酶谱法分析了基质金属蛋白酶(MMP)-2、MMP-9和膜型1-MMP(MT1-MMP)的表达及活性,以研究MMP是否与BM降解相关。在BM成分的免疫组织化学中,许多HSA在BM中显示出不连续的线性/阴性免疫反应(IV型胶原分别为49.4%/14.5%,层粘连蛋白分别为60.3%/10.8%)。相比之下,几乎所有血管瘤在BM中都显示出连续染色(IV型胶原为90.9%,层粘连蛋白为95.5%)。有趣的是,分别在97.6%和91.6%的HSA中观察到IV型胶原和层粘连蛋白的阳性细胞质免疫反应。虽然在肿瘤性和活跃血管生成的内皮细胞(EC)中未检测到MMP-9免疫反应,但在GT的所有EC以及两种血管肿瘤的肿瘤细胞中均检测到MMP-2。在GT的活跃血管生成EC和HSA的肿瘤EC中观察到MT1-MMP的强免疫反应。然而,几乎所有血管瘤都显示出弱/阴性免疫反应。在明胶酶谱法中,在HSA中观察到活性MMP-2的显著强活性,类似于GT中活跃血管生成的情况;然而,在血管瘤中检测到活性MMP-2的弱/无活性。在犬HSA中,肿瘤细胞具有活性MMP-2,可能由MT1-MMP激活,并且BM的不连续状态可能与活性MMP-2的活性相关。